AKRO - Akero Therapeutics prices equity offering at $36 July, 08 2020 04:35 AM Akero Therapeutics Inc. Akero Therapeutics (NASDAQ:AKRO) has priced its public offering of 5,228,166 common shares at $36.00/share, for expected gross proceeds of ~$188.2M.More news on: Akero Therapeutics, Inc., Healthcare stocks news, , Read more ...